HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Soyka Selected Research

Methadone (Dolophine)

9/2021Recent advances in the treatment of opioid use disorders-focus on long-acting buprenorphine formulations.
1/2021Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.
1/2021Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update.
9/2019[New slow-release buprenorphine formulations for optimization of opioid substitution].
12/2017Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
1/2017Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
1/2017Treatment of opioid dependence with buprenorphine: current update.
10/2016Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine.
2/2015Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.
1/2015Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Soyka Research Topics

Disease

43Alcoholism (Alcohol Abuse)
01/2021 - 01/2002
27Opioid-Related Disorders (Opiate Addiction)
12/2022 - 01/2005
10Substance-Related Disorders (Drug Abuse)
09/2020 - 02/2003
7Fibrosis (Cirrhosis)
01/2021 - 01/2011
6Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2021 - 01/2004
6Cognitive Dysfunction
11/2019 - 10/2005
4Mental Disorders (Mental Disorder)
01/2021 - 02/2003
4Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
01/2018 - 01/2011
4Schizophrenia (Dementia Praecox)
01/2015 - 01/2005
3Tobacco Use Disorder (Nicotine Dependence)
01/2018 - 03/2016
2Depressive Disorder (Melancholia)
04/2019 - 09/2017
2Personality Disorders (Personality Disorder)
01/2018 - 09/2003
2Infections
12/2017 - 04/2009
2Cocaine-Related Disorders (Cocaine Addiction)
10/2016 - 03/2016
2Hepatitis C
01/2005 - 02/2003
1Meningitis
03/2022
1Mastoiditis
03/2022
1Weight Loss (Weight Reduction)
01/2021
1Alcohol-Related Disorders
01/2021
1Fatty Liver
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Prediabetic State (Prediabetes)
01/2021
1Obesity
01/2021
1Serotonin Syndrome (Syndrome, Serotonin)
09/2020
1Wounds and Injuries (Trauma)
09/2020
1Multiple Trauma (Multiple Injuries)
09/2020
1Chronic Pain
11/2019
1Hypoxia (Hypoxemia)
12/2018
1Parkinson Disease (Parkinson's Disease)
10/2018
1Sleepiness
10/2018
1Rheumatoid Arthritis
10/2018
1Back Pain (Backache)
10/2018
1Dizziness (Lightheadedness)
10/2018
1Sleep Initiation and Maintenance Disorders (Insomnia)
10/2018
1Pancreatitis
10/2018
1Epilepsy (Aura)
01/2018
1Ascites
01/2018
1Binge Drinking
01/2018
1Nasal Septal Perforation
05/2017
1Amphetamine-Related Disorders (Addiction, Amphetamine)
02/2017

Drug/Important Bio-Agent (IBA)

24Methadone (Dolophine)FDA LinkGeneric
09/2021 - 02/2003
20Buprenorphine (Subutex)FDA LinkGeneric
09/2021 - 01/2005
20Opioid Analgesics (Opioids)IBA
01/2021 - 01/2005
12Naltrexone (ReVia)FDA LinkGeneric
01/2018 - 12/2002
9Pharmaceutical PreparationsIBA
01/2021 - 01/2003
8Narcotic Antagonists (Opioid Antagonists)IBA
10/2016 - 01/2003
7Acamprosate (Campral)FDA Link
10/2016 - 01/2002
6Biological ProductsIBA
01/2019 - 01/2008
4EnzymesIBA
01/2018 - 12/2002
4nalmefene (Revex)FDA Link
01/2016 - 11/2008
4Naloxone Drug Combination BuprenorphineFDA Link
02/2015 - 11/2012
3Topiramate (Topamax)FDA LinkGeneric
01/2021 - 08/2017
3BenzodiazepinesIBA
04/2019 - 01/2005
3Heroin (Diamorphine)IBA
12/2018 - 08/2008
3Ethanol (Ethyl Alcohol)IBA
05/2017 - 04/2005
3Antipsychotic Agents (Antipsychotics)IBA
02/2009 - 04/2003
2Gabapentin (Neurontin)FDA LinkGeneric
01/2021 - 08/2017
2Transaminases (Aminotransferases)IBA
10/2020 - 01/2011
2Protein Isoforms (Isoforms)IBA
10/2018 - 01/2009
2BilirubinIBA
01/2018 - 09/2012
2Cocaine (Cocaine HCl)IBA
10/2016 - 04/2015
2Disulfiram (Antabuse)FDA Link
10/2016 - 12/2010
2Naloxone (Narcan)FDA LinkGeneric
02/2015 - 09/2013
2Methionine (L-Methionine)FDA Link
01/2015 - 09/2011
2Opioid Receptors (Opioid Receptor)IBA
01/2015 - 07/2012
2Dopamine (Intropin)FDA LinkGeneric
03/2012 - 09/2011
2Alanine Transaminase (SGPT)IBA
01/2011 - 02/2003
1Opiate AlkaloidsIBA
12/2022
1Anti-Bacterial Agents (Antibiotics)IBA
03/2022
1Calcium Sulfate (Alabaster)IBA
03/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1ChemokinesIBA
01/2021
1TeaIBA
01/2021
1FlagellinIBA
01/2021
1CoffeeFDA Link
01/2021
1Toll-Like Receptor 5IBA
01/2021
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2021
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
09/2020
1Hallucinogens (Psychedelics)IBA
09/2020
1Methamphetamine (Desoxyn)FDA LinkGeneric
11/2019
1Antidepressive Agents (Antidepressants)IBA
04/2019
1Eszopiclone (Lunesta)FDA Link
10/2018
1TrypsinogenIBA
10/2018
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2018
1N 30IBA
09/2017
1Varenicline (Chantix)FDA Link
08/2017
1PolydioxanoneIBA
05/2017
1Modafinil (Provigil)FDA Link
10/2016
1Methylphenidate (Ritalin)FDA LinkGeneric
10/2016
1LipidsIBA
12/2015
1Illicit Drugs (Recreational Drugs)IBA
04/2015
1Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
04/2015
14-Butyrolactone (gamma Butyrolactone)IBA
04/2015

Therapy/Procedure

19Therapeutics
09/2020 - 01/2002
9Drug Therapy (Chemotherapy)
09/2021 - 04/2003
6Opiate Substitution Treatment
01/2021 - 08/2008
5Secondary Prevention
11/2008 - 01/2002
1Deep Brain Stimulation
10/2016
1Transcranial Magnetic Stimulation
10/2016
1Liver Transplantation
12/2015